John Glenn - 11 Dec 2024 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Issuer symbol
IRMD
Transactions as of
11 Dec 2024
Net transactions value
$0
Form type
4
Filing time
13 Dec 2024, 16:00:04 UTC
Previous filing
02 Dec 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Award $0 +5,436 +15% $0.000000 40,508 11 Dec 2024 Common Stock 5,436 Direct F1, F2
transaction IRMD Performance-based Restricted Stock Units Award $0 +5,435 +31% $0.000000 23,119 11 Dec 2024 Common Stock 5,435 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
F3 The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. PRSUs convert into common stock on a one-for-one basis. The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.